搜尋結果
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Reuters· 12 小時前Cigna plans to make close copies of AbbVie's blockbuster arthritis drug Humira available ...
PE firm GTCR to buy wealth management platform AssetMark for $2.7 bln
Reuters· 13 小時前, opens new tab, in a deal that would take the wealth management platform private more than five years after its initial ...
Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
The Wall Street Journal· 18 小時前Bristol-Myers Squibb’s market capitalization has dropped so much over the past year that it is now arguably no longer part ...
Jim Cramer shares his thoughts on Caterpillar, Dow, Chipotle, Merck and ServiceNow
CNBC· 18 小時前Caterpillar : The machinery giant reported mixed results, with earnings per share topping Wall ...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters· 19 小時前GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them ...
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
CNBC· 22 小時前... reported first-quarter revenue that topped expectations as its blockbuster< ... ...
BHP Bid for Anglo American Set to Unleash Wave of Mining M&A
Bloomberg· 22 小時前Have a confidential tip for our reporters? Today, reporter Mark Burton discusses how BHP’s bid ...
Bristol Myers Beats on Revenue as Revlimid Sales Decline Slows
Bloomberg· 22 小時前Have a confidential tip for our reporters? The company will eliminate 2,200 jobs this year and ...
For Beaten-Down Maker of Alzheimer’s Drug, Good Enough Will Do
The Wall Street Journal· 22 小時前In-line sales for Alzheimer’s drug Leqembi and a beat for rare-disease drug Skyclarys has Wall ...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 22 小時前... its annual profit and revenue forecast on the back of strong sales for its blockbuster ... ...